Breaking News

Fujifilm Diosynth Biotechnologies Expands UK Operations

Opens cell culture process development laboratories in Wilton Centre

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) with experience focused on the development and manufacture of recombinant biopharmaceuticals and advanced therapies, has opened its 10,000 square foot, state-of-the-art cell culture process development laboratories in Wilton Centre, Teesside, UK. These laboratories were realized through a $9 million investment, which is part of the greater $130 million expansion announced by Fujifilm Corporation in Ap...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters